Drugs@FDA document
FYLNETRA Review · BLA 761084 ORIG-1
Drugs@FDA document · KASHIV BIOSCIENCES LLC · Jul 15, 2022
Key facts
| Drug name | FYLNETRA |
|---|---|
| Document type | Review |
| Application | BLA761084 |
| Submission | ORIG-1 |
| Company | KASHIV BIOSCIENCES LLC |
| Document date | Jul 15, 2022 |
| FDA document | accessdata.fda.gov |
At a glance
- 10–99 Documents for this application
- 1–9 USP chapters cited in this application's documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: